Penumbra Stock Performance
| PEN Stock | USD 341.84 1.92 0.56% |
On a scale of 0 to 100, Penumbra holds a performance score of 14. The company holds a Beta of 0.4, which implies possible diversification benefits within a given portfolio. As returns on the market increase, Penumbra's returns are expected to increase less than the market. However, during the bear market, the loss of holding Penumbra is expected to be smaller as well. Please check Penumbra's expected short fall, and the relationship between the maximum drawdown and rate of daily change , to make a quick decision on whether Penumbra's historical price patterns will revert.
Risk-Adjusted Performance
Good
Weak | Strong |
Compared to the overall equity markets, risk-adjusted returns on investments in Penumbra are ranked lower than 14 (%) of all global equities and portfolios over the last 90 days. In spite of very weak technical and fundamental indicators, Penumbra displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Actual Historical Performance (%)
One Day Return (4.52) | Five Day Return (5.08) | Year To Date Return 9.86 | Ten Year Return 648.89 | All Time Return 723.05 |
Last Split Factor 1:10 | Last Split Date 2014-11-16 |
1 | Acquisition by Johanna Roberts of 3580 shares of Penumbra subject to Rule 16b-3 | 11/17/2025 |
2 | Penumbra Director Harpreet Grewal Sells 100 Shares | 12/04/2025 |
3 | Needham raises Penumbra stock price target to 388 on growth outlook - Investing.com Nigeria | 12/17/2025 |
4 | Why Penumbra is a Top Momentum Stock for the Long-Term | 01/12/2026 |
5 | Penumbra, Inc. Provides Preliminary Update on Fourth Quarter and Full Year 2025 Financial Results | 01/15/2026 |
6 | Penumbra Climbs to All-Time High on 14.5-Billion Merger | 01/16/2026 |
7 | 3 takeaways from Boston Scientifics 14.5B Penumbra deal | 01/20/2026 |
8 | Lance Uranium Reset Signals New Phase for Peninsula Energy | 01/22/2026 |
9 | Boston Scientific Penumbra Deal Recasts Growth Prospects In Thrombectomy And Neurovascular | 01/23/2026 |
10 | Peninsula Energy Valuation Check As Lance Reset Progresses Ahead Of Schedule | 01/26/2026 |
11 | Boston Scientific Buyout Caps Penumbra Upside And Shifts Investor Focus | 01/27/2026 |
12 | Boston Scientific Earnings Transcript | 02/04/2026 |
| Begin Period Cash Flow | 167.5 M | |
| Total Cashflows From Investing Activities | 77.6 M |
Penumbra Relative Risk vs. Return Landscape
If you would invest 26,619 in Penumbra on November 7, 2025 and sell it today you would earn a total of 7,373 from holding Penumbra or generate 27.7% return on investment over 90 days. Penumbra is generating 0.4352% of daily returns assuming volatility of 2.3698% on return distribution over 90 days investment horizon. In other words, 21% of stocks are less volatile than Penumbra, and above 92% of all equities are expected to generate higher returns over the next 90 days. Expected Return |
| Risk |
Penumbra Target Price Odds to finish over Current Price
The tendency of Penumbra Stock price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 341.84 | 90 days | 341.84 | about 15.21 |
Based on a normal probability distribution, the odds of Penumbra to move above the current price in 90 days from now is about 15.21 (This Penumbra probability density function shows the probability of Penumbra Stock to fall within a particular range of prices over 90 days) .
Penumbra Price Density |
| Price |
Predictive Modules for Penumbra
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as Penumbra. Regardless of method or technology, however, to accurately forecast the stock market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the stock market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Penumbra's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Penumbra Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. Penumbra is not an exception. The market had few large corrections towards the Penumbra's value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold Penumbra, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of Penumbra within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 0.60 | |
β | Beta against Dow Jones | 0.40 | |
σ | Overall volatility | 34.78 | |
Ir | Information ratio | 0.18 |
Penumbra Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Penumbra for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Penumbra can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Boston Scientific Earnings Transcript |
Penumbra Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Penumbra Stock often depends not only on the future outlook of the current and potential Penumbra's investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Penumbra's indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 39.3 M | |
| Cash And Short Term Investments | 340.1 M |
Penumbra Fundamentals Growth
Penumbra Stock prices reflect investors' perceptions of the future prospects and financial health of Penumbra, and Penumbra fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Penumbra Stock performance.
| Return On Equity | 0.13 | ||||
| Return On Asset | 0.067 | ||||
| Profit Margin | 0.12 % | ||||
| Operating Margin | 0.14 % | ||||
| Current Valuation | 13.75 B | ||||
| Shares Outstanding | 39.23 M | ||||
| Price To Earning | 191.13 X | ||||
| Price To Book | 10.31 X | ||||
| Price To Sales | 10.47 X | ||||
| Revenue | 1.19 B | ||||
| Gross Profit | 890.99 M | ||||
| EBITDA | 45.99 M | ||||
| Net Income | 14.01 M | ||||
| Cash And Equivalents | 324.4 M | ||||
| Cash Per Share | 5.39 X | ||||
| Total Debt | 223.39 M | ||||
| Debt To Equity | 0.23 % | ||||
| Current Ratio | 4.93 X | ||||
| Book Value Per Share | 34.70 X | ||||
| Cash Flow From Operations | 168.48 M | ||||
| Earnings Per Share | 4.20 X | ||||
| Market Capitalization | 13.97 B | ||||
| Total Asset | 1.53 B | ||||
| Retained Earnings | 60 M | ||||
| Working Capital | 792.78 M | ||||
| Current Asset | 244.36 M | ||||
| Current Liabilities | 28.15 M | ||||
About Penumbra Performance
By examining Penumbra's fundamental ratios, stakeholders can obtain critical insights into Penumbra's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Penumbra is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
| Last Reported | Projected for Next Year | ||
| Days Of Inventory On Hand | 303.93 | 262.60 | |
| Return On Tangible Assets | 0.01 | 0.01 | |
| Return On Capital Employed | 0.01 | 0.01 | |
| Return On Assets | 0.01 | 0.01 | |
| Return On Equity | 0.01 | 0.01 |
Things to note about Penumbra performance evaluation
Checking the ongoing alerts about Penumbra for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Penumbra help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Over 98.0% of the company shares are owned by institutional investors | |
| Latest headline from finance.yahoo.com: Boston Scientific Earnings Transcript |
- Analyzing Penumbra's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Penumbra's stock is overvalued or undervalued compared to its peers.
- Examining Penumbra's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Penumbra's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Penumbra's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Penumbra's stock. These opinions can provide insight into Penumbra's potential for growth and whether the stock is currently undervalued or overvalued.
Check out Your Equity Center to better understand how to build diversified portfolios, which includes a position in Penumbra. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in services. To learn how to invest in Penumbra Stock, please use our How to Invest in Penumbra guide.You can also try the Fundamental Analysis module to view fundamental data based on most recent published financial statements.
Will Health Care Equipment & Supplies sector continue expanding? Could Penumbra diversify its offerings? Factors like these will boost the valuation of Penumbra. Anticipated expansion of Penumbra directly elevates investor willingness to pay premium valuations. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Penumbra data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
Quarterly Earnings Growth 0.56 | Earnings Share 4.2 | Revenue Per Share | Quarterly Revenue Growth 0.178 | Return On Assets |
Investors evaluate Penumbra using market value (trading price) and book value (balance sheet equity), each telling a different story. Calculating Penumbra's intrinsic value - the estimated true worth - helps identify when the stock trades at a discount or premium to fair value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. External factors like market trends, sector rotation, and investor psychology can cause Penumbra's market price to deviate significantly from intrinsic value.
It's important to distinguish between Penumbra's intrinsic value and market price, which are calculated using different methodologies. Investment decisions regarding Penumbra should consider multiple factors including financial performance, growth metrics, competitive position, and professional analysis. Conversely, Penumbra's market price signifies the transaction level at which participants voluntarily complete trades.